ENT Devices Market Overview

The global ENT devices market was valued at USD 27.30 billion in 2024 and is projected to reach USD 37.72 billion by 2030, expanding at a CAGR of 5.5% from 2025 to 2030. The growing prevalence of hearing loss and impairment has become a major global public health concern, particularly in developed economies.

Hearing loss is among the most widespread medical conditions worldwide. According to the World Health Organization (WHO) factsheet released in February 2024, approximately 5% of the global population requires rehabilitation to manage hearing loss. Furthermore, by 2050, around 2.5 billion individuals are expected to experience some level of hearing impairment, with about 700 million likely to need hearing rehabilitation. The increasing life expectancy and rising noise pollution levels are key factors driving this surge in hearing-related conditions.

In lower-income countries, infectious diseases such as measles, middle ear infections, and meningitis remain common causes of hearing impairment. Other contributing factors include chronic inflammation, vascular disorders, natural aging processes, exposure to loud noises, and genetic predisposition. According to the European Hearing Instrument Manufacturers Association (EHIMA), hearing aid unit sales by its members rose by 4.7% in 2022, reaching 20.25 million units. This growth in hearing aid adoption, combined with the high global burden of hearing loss, is expected to drive the ENT devices market forward.

Order a free sample PDF of the ENT Devices Market Intelligence Study, published by Grand View Research.

Key Market Trends & Insights

• North America dominated the ENT devices market in 2024, accounting for the largest revenue share of 34.99%.
• The U.S. market held the majority share within North America, representing 90.35% of regional revenues in 2024.
• By product type, the hearing aids segment led the market, contributing the largest revenue share of 31.06% in 2024.

Market Size & Forecast

• 2024 Market Size: USD 27.30 Billion
• 2030 Projected Market Size: USD 37.72 Billion
• CAGR (2025–2030): 5.5%
• Largest Market (2024): North America

Key ENT Devices Company Insights

Major players in the ENT devices industry are focusing on innovation, product diversification, and strategic partnerships to strengthen their market positions. Companies are investing heavily in research and development, mergers & acquisitions, and global expansion to enhance product accessibility and technological capabilities. The growing emphasis on minimally invasive procedures, hearing restoration technologies, and digital hearing aid integration continues to shape the competitive landscape.

Key ENT Devices Companies

• Ambu A/S
• Cochlear Ltd.
• Demant A/S
• Sonova
• GN Store Nord A/S
• Karl Storz
• Olympus Corporation
• PENTAX Medical
• Richard Wolf GmbH
• Rion Co., Ltd.
• Smith & Nephew plc
• Starkey Laboratories, Inc.
• Stryker
• MED-EL Medical Electronics
• Nemera

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The ENT devices market is witnessing steady growth driven by the rising global incidence of hearing loss, technological advancements in auditory care, and the increasing adoption of minimally invasive solutions. Growing awareness about hearing health and strong demand for innovative hearing aids are contributing significantly to market expansion. With North America leading in revenue share and continuous innovation from key players like Sonova, Cochlear, and GN Store Nord, the industry is expected to maintain a strong growth trajectory through 2030, focusing on improved patient outcomes and expanded access to hearing care solutions.